Announcements Trials
Browse Landscape

Phase

Phase 2 135Phase 1 50Phase 3 47Phase 1/2 35Phase NA 19Phase 2/3 3Phase EARLY_PHASE1 2

Status

Completed 12Active not recruiting 6Recruiting 5Withdrawn 3Terminated 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1

Conditions

Pelvic Neoplasms 1Neoplasm Metastasis 1

Interventions

Magnetic Resonance Spectroscopy 7Cyclophosphamide 6pembrolizumab 5Radiosurgery 5Nivolumab 4Fluorouracil 4Carboplatin 4Blood Specimen Collection 4Biopsy 4X-Rays 3Vincristine 3Surveys and Questionnaires 3Proflavine 3Positron-Emission Tomography 3Metformin 3Cisplatin 3Bevacizumab 3fludarabine phosphate 2durvalumab 2atezolizumab 2Varenicline 2Topotecan 2Taxes 2Specimen Handling 2Rituximab 2Radiotherapy 2Positron Emission Tomography Computed Tomography 2Oxaliplatin 2Leucovorin 2Letrozole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Radiotherapy × Clear all
NCT04199754 2024-05-31

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Columbia University

Phase EARLY_PHASE1 Terminated
6 enrolled
Gynecologic

Pelvic Neoplasms

NCT01427322 2015-07-08

Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease

Virginia Commonwealth University

Phase EARLY_PHASE1 Terminated
6 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡